دورية أكاديمية

The addition of pembrolizumab to neoadjuvant chemoradiotherapy did not increase the risk of developing postoperative anastomotic leakage for ESCC: an analysis from a prospective cohort

التفاصيل البيبلوغرافية
العنوان: The addition of pembrolizumab to neoadjuvant chemoradiotherapy did not increase the risk of developing postoperative anastomotic leakage for ESCC: an analysis from a prospective cohort
المؤلفون: Qi, Wei-XiangAff1, Aff2, Li, ShuyanAff1, Aff2, Li, HuanAff1, Aff2, Chen, JiayiAff1, Aff2, IDs1288502412774w_cor4, Zhao, ShengguangAff1, Aff2, IDs1288502412774w_cor5
المصدر: BMC Cancer. 24(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:14712407
DOI:10.1186/s12885-024-12774-w